http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009082106-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a09ca043d7e596facff1f44b746e2f4d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_370ca28a580f6b11f2ed9bd04a153e55 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-205 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 |
| filingDate | 2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfb2b9fcee39ce2d1ccf03c8ca9a5801 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_498cb6f6354a132ae2317fa8d123d5dd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9776ea1858b2793c08ca09504f2880db |
| publicationDate | 2009-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2009082106-A |
| titleOfInvention | Polypeptide derived from Helicobacter sinedi and method for using the same |
| abstract | [PROBLEMS] To provide a recombinant polypeptide (molecular weight 30 kD) derived from H. cinaedi and a serological diagnostic method for patients with Helicobacter cinedi infection using the same. As a solid phase antigen, a polypeptide having a specific amino acid sequence, (1) capable of binding to the serum of a patient infected with Helicobacter sinedi and (2) deletion or addition of one or several amino acid residues Or the polypeptide having the characteristic of having a substituted amino acid sequence, a peptide comprising a part of the polypeptide, and any one of the above-mentioned peptides capable of binding to the serum of a patient infected with Helicobacter cinedi or A serological diagnosis method for patients with Helicobacter cinedi infection, which comprises an antigen-antibody method using peptides. The serological diagnostic method may be selected from the group consisting of ELISA, Western blot, and dot blot. [Selection figure] None |
| priorityDate | 2007-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.